Shockwave IVL maintains ‘superiority’ to angioplasty in calcified peripheral disease at two years

Shockwave Medical announced today that long-term data from the Disrupt PAD III trial found that superior vessel preparation with intravascular lithotripsy (IVL) led to excellent long-term outcomes out to two years with preservation of future treatment options compared to percutaneous transluminal angioplasty (PTA)…
SCAI issues position paper on transaxillary arterial access

The Society for Cardiovascular Angiography & Interventions (SCAI) has released an official position statement providing evidence-based recommendations for percutaneous transaxillary arterial access and training for clinicians. The document was published in the Journal of the Society for Cardiovascular Angiography &…

